Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Outcomes are better for patients with total coronary artery occlusions when percutaneous coronary intervention is performed with sirolimus-eluting stents rather than with bare…
Zachary T. Bloomgarden, MD, Editor of the Journal of Diabetes and a Clinical Professor at the Mount Sinai School of Medicine, provides a critical analysis of the recent…
NEW YORK (Reuters Health) – Eptifibatide and tirofiban are effective alternatives to abciximab given during primary percutaneous intervention for ST-elevation MI, according to the results of a meta-analysis…
NEW YORK (Reuters Health) – Bedside ultrasound can reliably diagnose clavicle fractures in children seen in the emergency department, with no more discomfort than radiographs — and without…
NEW YORK (Reuters Health) – On a matched-pair analysis, the results of decompressive surgery followed by radiotherapy for metastatic spinal cord compression were seen to be similar to…
NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer who have not had a recurrence for 5 years after resection may not yet be free and clear.…
NEW YORK (Reuters Health) – A South African study shows that HIV-infected patients do better when they begin treatment above rather than below 200 cells/µL. The results, reported…
NEW YORK (Reuters Health) – Results of primary percutaneous intervention (PCI) in patients with ST-segment elevation MI are better when the procedure is performed via the radial artery…
NEW YORK (Reuters Health) – According to a new report, primary care patients who may have a drug use disorder can be reliably identified with a single-question screening…
NEW YORK (Reuters Health) – Updated guidelines issued by the American Society of Clinical Oncology (ASCO) recommend that postmenopausal women with hormone receptor-positive breast cancer should receive aromatase…
